LOL....this company wont need to do anything to uplist...especially R/S. As a matter of fact, I wouldn't doubt it if they never get the chance to uplist before they are bought out. Potential suitors to buy us out will want to pay while we are in OTC, not after we have worldwide superior medical patents and are uplisted getting DEEP pocket money thrown our way by monster investors. They want us as cheaply as they can buy us and that is why once this approval gets processed, we will be scooped up immediately by a BIG medical company for $B's.